Literature DB >> 1082732

Family distribution of lymphocytotoxins in Hodgkin's disease.

J R Mendius, R J DeHoratius, R P Messner, R C Williams.   

Abstract

The prevalence of lymphocytotoxic antibody was studied in 131 relatives of 10 patients with Hodgkin's disease. The study group contained nine families, five of which had two subjects with Hodgkin's disease. One hundred twenty-eight control family members were studied in parallel. Lymphocytotoxic antibody was present in 35.5% of all family members of patients with Hodgkin's disease, and in 8.6% of controls (P less than 0.01). Lymphocytotoxic antibody appeared primarily in consanguineous relatives irrespective of close personal household contact with the probands. The prevalence of the antibody was equal in both first- and second-degree relatives. These findings suggest at least a genetic and possibly an environmental influence in the genesis of lymphocytotoxic antibody among relatives of patients with Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082732     DOI: 10.7326/0003-4819-84-2-151

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

1.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  A study of lymphocytotoxins in families of patients with systemic lupus erythematosus.

Authors:  R A Hazelton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners.

Authors:  G E Ozturk; P F Kohler; C R Horsburgh; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

4.  Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.

Authors:  C Huber; R Pfister; G Stingl
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

Review 5.  Diseases associated with immunosuppression.

Authors:  E R Heise
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.